August 17–21, 2025, Washington, DC, USA - Visit us at Booth 2230.

Email:
Phone:

Get A Quote

Rancinamycin III

Name: Rancinamycin III
Brand: BOC Sciences
Rating: 5 (1 reviews)

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Category	Antibiotics
Catalog number	BBF-02176
CAS	60925-60-2
Molecular Weight	174.15
Molecular Formula	C7H10O5
Purity	>97%

Online Inquiry

Capabilities & Facilities

Fermentation Lab

4 R&D and scale-up labs

2 Preparative purification labs

Fermentation Plant

Semi pilot, pilot and industrial plant 4 Manufacturing sites 7 Production lines at pilot scale 100+ Reactors of 30-4000 L; 170+ reactors of 20 KL-30 KL; 24+ reactors of >100 KL 2 Hydrogenation reactors (200 L, 4Mpa and 1000L, 4Mpa)

Product Description

Rancinamycin III is an antibiotic that has antibacterial properties originally isolated from Str. lincolnensis.

Specification
Reference Reading
Price Product List

Synonyms	SCHEMBL16431322
IUPAC Name	3,4,5,6-tetrahydroxycyclohexene-1-carbaldehyde
Canonical SMILES	C1=C(C(C(C(C1O)O)O)O)C=O
InChI	InChI=1S/C7H10O5/c8-2-3-1-4(9)6(11)7(12)5(3)10/h1-2,4-7,9-12H
InChI Key	KQQCGAKRCKYICB-UHFFFAOYSA-N

1. Rancinamycins I, II, III and IV structural studies

A D Argoudelis, R W Sprague, S A Mizsak J Antibiot (Tokyo). 1976 Aug;29(8):787-96. doi: 10.7164/antibiotics.29.787.

Rancinamycins are secondary metabolites produced by Streptomyces lincolnensis in a sulfur-depleted culture medium. The structures (except stereochemistry) of the main components of the rancinamycin-complex were determined by the use of IR, UV, PMR, and CMR spectra.

2. Rancinamycins, metabolites produced by Streptomyces lincolnensis in sulfur-depleted media

A D Argoudelis, T R Pyke, R W Sprague J Antibiot (Tokyo). 1976 Aug;29(8):777-86. doi: 10.7164/antibiotics.29.777.

Rancinamycins I, II, III, and IV are secondary metabolites produced by Streptomyces lincolnensis in a sulfur-depleted culture medium. Rancinamycins I, and II, the main components of the mixture, show broad spectrum antibiotic activity in vitro. Subcutaneously injected or orally administered antibiotic afforded no protection for experimentally infected mice against lethal challenges of Staphylococcus aureus. Radioactive tracer studies failed to demonstrate that the rancinamycin were precursors in the biosynthesis of lincomycin.

BBF-03868	Honokiol	Inquiry
BBF-03819	Spinosyn A	Inquiry
BBF-04609	1,1-Dimethylbiguanide hydrochloride	Inquiry
BBF-05734	Irofulven	Inquiry
BBF-03881	Sancycline	Inquiry
BBF-05806	Zeaxanthin	Inquiry

Bio Calculators

Solution Dilution Calculator
Molecular Weight Calculator
Molarity Calculator

Stock concentration: *

Desired final volume: *

Desired concentration: *

* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C₁V₁ = C₂V₂

Calculate

* Total Molecular Weight:

g/mol

Tip: Chemical formula is case sensitive. C22H30N4O √ c22h30n40 ╳

Formula weight: *

g/mol

Desired final volume: *

Desired concentration: *

Online Inquiry

*Name:

*Phone:

*Email:

*Quantity:

*Service & Products Interested:

Project Description:

Rancinamycin III

Capabilities & Facilities

Product Description

Bio Calculators

Recently viewed products

Online Inquiry